标题
Does COVID-19 Cause Non-Dıpper Hypertension?
作者
关键词
-
出版物
ANGIOLOGY
Volume -, Issue -, Pages -
出版商
SAGE Publications
发表日期
2023-10-21
DOI
10.1177/00033197231209584
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study
- (2022) Figen Öztürk Ergür et al. Sao Paulo Medical Journal
- Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients
- (2022) Virginie Montiel et al. EBioMedicine
- The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies
- (2022) Dang The Hung et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
- (2021) Stephany Beyerstedt et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Arterial stiffness in acute COVID‐19 and potential associations with clinical outcome
- (2021) Sebastian Schnaubelt et al. JOURNAL OF INTERNAL MEDICINE
- Hypertension, a Moving Target in COVID-19
- (2021) Carmine Savoia et al. CIRCULATION RESEARCH
- Carotid stiffness, intima–media thickness and aortic augmentation index among adults with SARS‐CoV‐2
- (2021) Rachel E. Szeghy et al. EXPERIMENTAL PHYSIOLOGY
- Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
- (2021) Aris T. Papageorghiou et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19
- (2021) Luise Hassler et al. Clinical Journal of the American Society of Nephrology
- Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
- (2021) Martina Zappa et al. European Journal of Internal Medicine
- Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination
- (2021) Sylvain Meylan et al. HYPERTENSION
- SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients
- (2021) Lucía Gutiérrez-Chamorro et al. Viruses-Basel
- Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
- (2021) Rimple Kaur et al. International Journal of General Medicine
- Does COVID-19 Cause Hypertension?
- (2021) Mahmut Akpek ANGIOLOGY
- Kidney injury in COVID-19 patients, drug development and their renal complications: Review study
- (2021) Zeynab Mohamadi Yarijani et al. BIOMEDICINE & PHARMACOTHERAPY
- Short term blood pressure alterations in recently COVID-19 vaccinated patients
- (2021) Elias Sanidas et al. European Journal of Internal Medicine
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Evaluation of the cardio-ankle vascular index in COVID-19 patients
- (2021) Ercan Aydın et al. Revista da Associacao Medica Brasileira
- Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
- (2021) Yahya Mahamat-Saleh et al. BMJ Open
- Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study
- (2021) Jiang-Shan Tan et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Renin-angiotensin system inhibitors in COVID-19
- (2020) George Thomas CLEVELAND CLINIC JOURNAL OF MEDICINE
- Angiotensin‐converting enzyme‐2 ( ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 ( COVID ‐19)
- (2020) Arno R. Bourgonje et al. JOURNAL OF PATHOLOGY
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID‐19 and arterial hypertension: Hypothesis or evidence?
- (2020) Marijana Tadic et al. Journal of Clinical Hypertension
- COVID-19 and Renal Diseases: An Update
- (2020) Letícia Bitencourt Cota et al. CURRENT DRUG TARGETS
- Long-term consequences of COVID-19: research needs
- (2020) Dana Yelin et al. LANCET INFECTIOUS DISEASES
- COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment
- (2020) Anant Parasher POSTGRADUATE MEDICAL JOURNAL
- COVID-19: from an acute to chronic disease? Potential long-term health consequences
- (2020) Victoria Higgins et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
- (2020) Francesca Salamanna et al. Frontiers in Medicine
- The renin‐angiotensin‐aldosterone system and its suppression
- (2019) Marisa K. Ames et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Arterial stiffness as a risk factor for clinical hypertension
- (2017) Michel E. Safar Nature Reviews Cardiology
- Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats
- (2016) Cameron G. McCarthy et al. AMERICAN JOURNAL OF HYPERTENSION
- Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats
- (2016) Cameron G. McCarthy et al. PHARMACOLOGICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started